Gujjarappa Srinivas, MD | |
600 S Dobson Rd, Suite# E 42, Chandler, AZ 85224-5678 | |
(480) 963-4183 | |
(480) 963-4184 |
Full Name | Gujjarappa Srinivas |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 29 Years |
Location | 600 S Dobson Rd, Chandler, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083623656 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 36889 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Mri And Diagnostic Llc | 6507859568 | 31 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.
New brain research is unlocking long-standing mysteries, explaining how the brain trains itself and how human beings develop their superior cognitive skills. New scanning tools (FMRI, SPECT, QEEG, etc.) are advancing neurology's understanding of a process called neuroplasticity and shedding light on a simple looking balance and movement regimen used since 1982 by developmental specialists to treat people with ADHD, Dyslexia and other learning differences.
For the first time, researchers using magnetic resonance imaging (MRI) have found both structural and functional abnormalities in specific brain regions of schizophrenic patients who experience chronic auditory hallucinations, according to a study published in the August issue of Radiology.
Research in the current issue of the Journal of Clinical Sleep Medicine is the first to show the full clinical picture of comorbid conditions associated with obstructive sleep apnea (OSA), quantify their frequency of occurrence and reveal their possible interrelationships.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it was pleased to learn of the partial success observed in the recently completed Phase 2b trial of a therapeutic HIV/AIDS vaccine produced by Bionor Immuno AS of Oslo, Norway.
› Verified 5 days ago
Entity Name | Memorial Mri And Diagnostic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912989120 PECOS PAC ID: 6507859568 Enrollment ID: O20051209000488 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.
New brain research is unlocking long-standing mysteries, explaining how the brain trains itself and how human beings develop their superior cognitive skills. New scanning tools (FMRI, SPECT, QEEG, etc.) are advancing neurology's understanding of a process called neuroplasticity and shedding light on a simple looking balance and movement regimen used since 1982 by developmental specialists to treat people with ADHD, Dyslexia and other learning differences.
For the first time, researchers using magnetic resonance imaging (MRI) have found both structural and functional abnormalities in specific brain regions of schizophrenic patients who experience chronic auditory hallucinations, according to a study published in the August issue of Radiology.
Research in the current issue of the Journal of Clinical Sleep Medicine is the first to show the full clinical picture of comorbid conditions associated with obstructive sleep apnea (OSA), quantify their frequency of occurrence and reveal their possible interrelationships.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it was pleased to learn of the partial success observed in the recently completed Phase 2b trial of a therapeutic HIV/AIDS vaccine produced by Bionor Immuno AS of Oslo, Norway.
› Verified 5 days ago
Entity Name | Miguel Oneto, Md, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669786950 PECOS PAC ID: 3476677600 Enrollment ID: O20100825000396 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.
New brain research is unlocking long-standing mysteries, explaining how the brain trains itself and how human beings develop their superior cognitive skills. New scanning tools (FMRI, SPECT, QEEG, etc.) are advancing neurology's understanding of a process called neuroplasticity and shedding light on a simple looking balance and movement regimen used since 1982 by developmental specialists to treat people with ADHD, Dyslexia and other learning differences.
For the first time, researchers using magnetic resonance imaging (MRI) have found both structural and functional abnormalities in specific brain regions of schizophrenic patients who experience chronic auditory hallucinations, according to a study published in the August issue of Radiology.
Research in the current issue of the Journal of Clinical Sleep Medicine is the first to show the full clinical picture of comorbid conditions associated with obstructive sleep apnea (OSA), quantify their frequency of occurrence and reveal their possible interrelationships.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it was pleased to learn of the partial success observed in the recently completed Phase 2b trial of a therapeutic HIV/AIDS vaccine produced by Bionor Immuno AS of Oslo, Norway.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Gujjarappa Srinivas, MD 600 S Dobson Rd, Suite# E 42, Chandler, AZ 85224-5678 Ph: (480) 963-4183 | Gujjarappa Srinivas, MD 600 S Dobson Rd, Suite# E 42, Chandler, AZ 85224-5678 Ph: (480) 963-4183 |
News Archive
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare. Daiichi Sankyo is seeking approval in Japan for edoxaban in new indications for non-valvular atrial fibrillation and symptomatic venous thromboembolism.
New brain research is unlocking long-standing mysteries, explaining how the brain trains itself and how human beings develop their superior cognitive skills. New scanning tools (FMRI, SPECT, QEEG, etc.) are advancing neurology's understanding of a process called neuroplasticity and shedding light on a simple looking balance and movement regimen used since 1982 by developmental specialists to treat people with ADHD, Dyslexia and other learning differences.
For the first time, researchers using magnetic resonance imaging (MRI) have found both structural and functional abnormalities in specific brain regions of schizophrenic patients who experience chronic auditory hallucinations, according to a study published in the August issue of Radiology.
Research in the current issue of the Journal of Clinical Sleep Medicine is the first to show the full clinical picture of comorbid conditions associated with obstructive sleep apnea (OSA), quantify their frequency of occurrence and reveal their possible interrelationships.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it was pleased to learn of the partial success observed in the recently completed Phase 2b trial of a therapeutic HIV/AIDS vaccine produced by Bionor Immuno AS of Oslo, Norway.
› Verified 5 days ago
Alice F. Tsai, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 695 S Dobson Rd, Chandler, AZ 85224 Phone: 480-821-2838 Fax: 480-821-9444 | |
Robert Baldwin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-821-3179 Fax: 480-821-3989 | |
Jay Boyer, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-821-3179 Fax: 480-821-3989 | |
Dr. Stamatis Kantartzis, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1955 W Frye Rd, Chandler, AZ 85224 Phone: 480-728-3000 | |
Janice R.l. Smith, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-821-3179 Fax: 480-821-3989 | |
Eric T Gross, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 695 S Dobson Rd, Chandler, AZ 85224 Phone: 480-821-2838 Fax: 480-821-9444 |